U.S. Markets open in 7 hrs 48 mins

KARYOPHARM THERAPEUTICS INC. (KPTI)


Nasdaq - Nasdaq Real Time Price. Currency in USD
Add to watchlist
10.22+0.01 (+0.10%)
At close: 4:00PM EDT
People also watch
EPZMXLRNMGNXOMEDPTCT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue154250229
Cost of Revenue---
Gross Profit154250229
Operating Expenses
Research Development86,93897,74460,127
Selling General and Administrative23,94821,58215,948
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-110,732-119,076-75,846
Income from Continuing Operations
Total Other Income/Expenses Net1,29489570
Earnings Before Interest and Taxes-109,438-118,181-75,776
Interest Expense--1
Income Before Tax-109,438-118,181-75,777
Income Tax Expense139--
Minority Interest---
Net Income From Continuing Ops-109,577-118,181-75,777
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-109,577-118,181-75,777
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-109,577-118,181-75,777